Last reviewed: April 2026
Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines experimental biology with AI to industrialize drug discovery.
Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines experimental biology with AI to industrialize drug discovery. Its proprietary platform has generated one of the world's largest biological and chemical datasets — over 50 petabytes of biological images — which it uses to discover new drug candidates at unprecedented speed. Recursion has multiple programs in clinical trials and partnerships with Roche, Bayer, and NVIDIA.
Recursion Pharmaceuticals is best suited for pharmaceutical companies, biotech r&d teams, drug discovery researchers at enterprise organizations. Not applicable — Recursion is a biotechnology company, not a SaaS platform. Revenue comes from drug development partnerships and milestone payments. pricing for biotech teams.
Key integrations: NVIDIA BioNeMo, AWS, Tempus, Roche R&D, Bayer Crop Science
Official website: Recursion Pharmaceuticals
Compare Recursion Pharmaceuticals with other platforms
The platform is designed to address the specific challenges faced by Biotech organizations. Key users include Pharmaceutical companies, Biotech R&D teams, Drug discovery researchers who rely on the platform for ai-accelerated drug target identification, high-throughput phenotypic screening, clinical candidate optimization. Deployment options include Hybrid, allowing organizations to choose the infrastructure setup that best fits their security and compliance requirements. The platform is scaled for Enterprise organizations seeking to modernize their drug discovery ai capabilities. In the rapidly evolving Biotech landscape, Recursion Pharmaceuticals stands out by combining drug discovery ai capabilities with industry-specific features that address the unique challenges of ai-accelerated drug target identification, high-throughput phenotypic screening, clinical candidate optimization. The platform enables Pharmaceutical companies and Biotech R&D teams to transition from manual, error-prone processes to automated, data-driven workflows that deliver consistent results at scale.
Before adopting Recursion Pharmaceuticals or any Drug Discovery AI solution for your biotech workflows, it is important to assess how the platform fits your specific requirements. Start by mapping your highest-priority pain points — whether that is reducing manual tasks, improving data accuracy, scaling customer interactions, or accelerating time to insight. Recursion Pharmaceuticals positions itself as a Drug Discovery AI solution, having been in the market since 2013, so evaluate whether its feature set directly addresses those pain points rather than relying on feature-list comparisons alone.
Request a live demo or proof-of-concept trial before committing to an annual contract. During the trial, measure concrete outcomes: task completion time, error rates, user adoption speed, and integration friction with your existing stack (Recursion Pharmaceuticals integrates with NVIDIA BioNeMo, AWS, Tempus, Roche R&D). Compare these metrics against at least two alternative vendors in the Drug Discovery AI space to establish a meaningful benchmark. Recursion Pharmaceuticals uses a Not applicable — Recursion is a biotechnology company, not a SaaS platform. Revenue comes from drug development partnerships and milestone payments. pricing model — make sure you understand the total cost of ownership including implementation, training, and any per-seat or usage-based fees.
Deployment options include Hybrid, so confirm which model meets your IT and compliance requirements. Recursion Pharmaceuticals holds FDA regulatory compliance, GLP/GCP, HIPAA certifications, which may be critical for regulated biotech use cases. Also ask about the vendor's SLA for uptime, support response times, and the data export process should you decide to switch providers in the future.
Recursion Pharmaceuticals is a Drug Discovery AI platform designed for biotech organizations. Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines experimental biology with AI to industrialize drug discovery.
Recursion Pharmaceuticals scores 9.5/10 on AI Scanner's independent evaluation. The score reflects performance (30%), usability (25%), pricing value (25%), and versatility (20%). Scores are updated monthly based on product changes, user feedback, and competitive benchmarking across Drug Discovery AI tools. Read our full scoring methodology.
The top alternative to Recursion Pharmaceuticals on AI Scanner is Isomorphic Labs (DeepMind) with a score of 9.4/10. Other alternatives include Insilico Medicine, Atomwise, Exscientia. Compare all alternatives.
Recursion Pharmaceuticals is designed for enterprise organizations. Its Not applicable — Recursion is a biotechnology company, not a SaaS platform. Revenue comes from drug development partnerships and milestone payments. pricing model scales with team size and usage requirements. We recommend running a pilot with your actual workflows before committing to a full deployment.
Recursion Pharmaceuticals uses a Not applicable — Recursion is a biotechnology company, not a SaaS platform. Revenue comes from drug development partnerships and milestone payments. pricing model. For the most accurate pricing, request a custom quote directly from the vendor. Pricing may vary based on deployment scale, feature tier, and contract length. Always factor in implementation and training costs when comparing total cost of ownership against competitors.
How We Score: AI Scanner evaluates platforms across four dimensions - Performance (30%), Usability (25%), Pricing Value (25%), and Versatility (20%). Scores are updated monthly. Read our full methodology.